Randall S. Edson, MD, Chair
Dr. Edson is currently the Internal Medicine Program Director at California Pacific Medical Center, San Francisco, California and also Clinical Professor of Medicine at the University of California, San Francisco. He is board certified in both Internal Medicine and Infectious Disease.
Previously, Dr. Edson was Professor of Medicine at the Mayo Clinic College of Medicine and had a 32-year career as an infectious diseases clinician and internal medicine clinician/educator. While at Mayo, Dr. Edson served as Program Director for the Infectious Diseases Fellowship Program and was a Senior Associate Program Director for the Internal Medicine Residency Program. In 2013, he was a recipient of the Distinguished Mayo Clinician award.
Dr. Edson currently serves on the Governor's Advisory Board for the Northern California Chapter of the American College of Physicians (ACP) and is Program Chair for the 2015 Annual Meeting of the All California Chapter of the ACP. Dr. Edson is Chair of the American Board of Internal Medicine (ABIM) Infectious Disease Board Exam Committee. He previously served on the ABIM Internal Medicine Exam Committee. He was awarded mastership in the American College of Physicians in April 2013.
Dr. Edson received a bachelor's degree in music history at Yale College and a master's degree in music from the Yale School of Music. He attended medical school at the University of Iowa and completed internal medicine residency and infectious diseases fellowship training at the Mayo School of Graduate Medical Education.
As of August 2020, Dr. Edson reported the following external relationships:
Dr. Edson serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- American College of Physicians, Northern California Chapter, Governor's Council, without compensation.
John W. Baddley, MD, MSPH
Dr. Baddley is a Professor of Medicine, Division of Infectious Diseases, at the University of Alabama at Birmingham (UAB). Dr. Baddley serves as Director, Transplant Infectious Diseases in the UAB Comprehensive Transplant Institute and as Chief of Infectious Diseases at the Birmingham VA Medical Center.
Dr. Baddley is board certified in Infectious Disease. He serves as a member of the American Board of Internal Medicine Infectious Disease Board Exam Committee. Dr. Baddley's research interests include the epidemiology, diagnosis and treatment of fungal infections; transplant infectious diseases; and infections associated with biologic therapies. He has authored or co-authored more than 150 papers, chapters and reviews. He also serves as an Associate Editor for Open Forum Infectious Diseases.
Dr. Baddley received his medical degree from Louisiana State University (LSU) School of Medicine, New Orleans. He completed an internship and residency at LSU Medical Center, and a fellowship in infectious diseases at University of Alabama at Birmingham, where he served as Chief Infectious Diseases Fellow.
As of August 2019, Dr. Baddley reported the following external relationships:
Funding for clinical trial expenses, salary support and staff, paid to the University of Alabama, from the following companies:
- Shire, for a study of maribavir versus stand-of-care for the treatment of refractory or resistant cytomegalovirus in transplant patients.
Service on data and safety monitoring boards for the following companies, with honoraria:
- Ansum Pharmaceuticals, advising on data and safety for a clinical trial, receiving honoraria.
- Eli Lilly & Company, advising on data and safety for a clinical trial, receiving honoraria.
- Pfizer, advising on evaluation of opportunistic infections among patients participating in clinical trials for tofacitinib, receiving honoraria.
- R-Pharm, relating to olokizumab and focusing on infection-related events, receiving honoraria.
Dr. Baddley serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Transplantation Society, Transplant Infectious Diseases Committee, Secretary/Treasurer, without compensation.
Christina M. Coyle, MD
Dr. Coyle is Professor of Clinical Medicine, specializing in infectious diseases, at The Albert Einstein College of Medicine. In 2007, she became the Assistant Dean for Faculty Development. Dr. Coyle is board certified in Infectious Disease and has special expertise in parasitology.
Dr. Coyle is recognized as an expert in the larval tapeworms, Echinococcus, and in neurocysticercosis. She has co-authored chapters and articles on these and many other tropical diseases. She has run an active tropical medicine clinic in the United States since 2006. In 2007, she became a site director for GeoSentinel, the global surveillance network of the International Society of Travel Medicine and the Centers for Disease Control. She also functions in the Infectious Disease Society of America and American Society Tropical Medicine and Hygiene (ASTM&H) panel on guidelines for neurocysticercosis. In addition, she co-directs the annual ASTM&H Update Course since 2008, which provides clinically relevant education in the field of tropical medicine and parasitology, in order to reduce global health disparities.
Dr. Coyle is a deeply committed educator. Since her faculty appointment at Einstein in 1995, she has served in many different roles in medical education and has been the recipient of almost every teaching award at Einstein. In 2007, she was appointed Course Director of Parasitology and Global Medicine Course in the second-year medical student curriculum, the only free-standing tropical medicine course at a U.S. medical school. Dr. Coyle is a much-sought-after teacher and lectures frequently at other medical schools in New York City. As of 2010, she also lectures in the parasitology section of the microbiology course at Columbia Medical School in New York City. She is a member of the American Board of Internal Medicine Infectious Disease Board Exam Committee.
Dr. Coyle is a graduate of Adelphi University and earned her medical degree at State University of New York-Downstate Medical Center. She completed her residency in internal medicine and a fellowship in infectious diseases at Bronx Municipal Hospital Center, and also holds a master of clinical research degree from Einstein.
As of August 2020, Dr. Coyle reported no external relationships.
Kimberly Hanson, MD
Dr. Hanson is an Associate Professor of Medicine and Pathology. She is Director of the Transplant Infectious Diseases and Immunocompromised Host Service at the University of Utah and Section Head for Clinical Microbiology within ARUP Laboratories.
Previously, Dr. Hanson was a faculty member and Associate Director of the Molecular Microbiology Laboratory at Duke University Medical Center.
Dr. Hanson is board certified in both Infectious Disease and Medical Microbiology. She serves as a member of the American Board of Internal Medicine Infectious Disease Board Exam Committee.
Dr. Hanson received her undergraduate and medical degrees from Northwestern University. She completed internal medicine training and was chief medical resident at Dartmouth-Hitchcock Medical Center. She then completed adult infectious diseases and medical microbiology fellowships at Duke University, followed by a master’s degree in health sciences from the same institution.
As of September 2019, Dr. Hanson reported the following external relationships:
Service on research-related panel or advisory boards for the following company, receiving honoraria:
- BioFire Diagnostics.
Work as an author or editor for following companies, with compensation as listed:
- American Society for Microbiology, receiving compensation as editor.
- Infectious Diseases Society of America, receiving compensation as editor.
Dr. Hanson serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Infectious Diseases Society of America, Diagnostics Policy Task Force member, without support, Associate Editor, receiving consulting fees.
- Clinical Laboratory Standards Institute, Subcommittee on Antifungal Susceptibility Testing, without support.
- Center for Medicare and Medicaid Services, Diagnostics Advisory Board, without support.
Howard M. Heller, MD
Dr. Heller is Associate Medical Director at the Massachusetts Institute of Technology (MIT), Associate Physician at Massachusetts General Hospital (MGH) in the infectious disease unit and Assistant Clinical Professor of Medicine, part-time, at Harvard Medical School. Dr. Heller is board certified in Internal Medicine and Infectious Disease.
At MIT, Dr. Heller practices primary care medicine and infectious disease and, as Associate Medical Director, is responsible for performance improvement, primary care, pediatrics, OB/GYN and mental health. He teaches in the Harvard-MIT Health Science and Technology (HST) program. At MGH, Dr. Heller serves on the infectious disease consult service, teaching and providing clinical care. He is a member of the American Board of Internal Medicine Infectious Disease Board Exam Committee.
Dr. Heller has previously served as President of the Massachusetts Infectious Disease Society and is currently a member of the board. He previously served on several committees of the AIDS Clinical Trial Group of the National Institutes of Health and was co-investigator of several clinical trials.
Dr. Heller received a bachelor's degree in biology from Columbia College of Columbia University and his medical degree from SUNY-Upstate Medical University, (Syracuse). He trained in internal medicine at North Shore University Hospital/Memorial Sloan Kettering Cancer Center (Cornell) and completed a fellowship in infectious diseases at SUNY-Stony Brook. He received a master's of public health degree from the Mailman School of Public Health of Columbia University. He is a Fellow of the Infectious Disease Society of America.
As of May 2019, Dr. Heller reported the following external relationship:
Dr. Heller reported that he serves as clinical advisor to Binx Health regarding sexually-transmitted infections home testing and point-of-care testing.
Costi Sifri, MD
Dr. Sifri is a Professor of Medicine, Division of Infectious Diseases and International Health, at the University of Virginia in Charlottesville, Virginia, where he serves as the Director, Hospital Epidemiology/Infection Prevention and Control, and Medical Director of the Immunocompromised Infectious Diseases Program for the University of Virginia Health System. Dr. Siffri is board certified in Infectious Diseases.
Dr. Sifri is board certified in Infectious Diseases. His research interests include healthcare-associated infection prevention, molecular epidemiology and pathogenesis of drug resistant bacterial infections, and infectious diseases prevention and treatment in medically immunocompromised individuals. He has authored or co-authored more than 120 papers, reviews, and chapters.
Dr. Sifri received his medical degree from the University of Rochester School of Medicine and Dentistry. He completed an internship and residency in internal medicine at the Hospital of the University of Pennsylvania, and a clinical and research fellowship training in infectious diseases at the Partners Infectious Diseases Program at Massachusetts General Hospital, Brigham and Women’s Hospital, and Harvard Medical School. He is a Fellow of the Infectious Disease Society of America.
As of April 2021, Dr. Sifri reported the following external relationship:
Dr. Sifri serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Society for Healthcare Epidemiology of America, Guidelines Committee Member, without compensation.
Stephen C. Threlkeld, MD
Dr. Threlkeld is board certified in Infectious Disease and has been Managing Partner of an infectious disease group practice for the past 20 years. He is an Assistant Clinical Professor of Medicine at the University of Tennessee Center for the Health Sciences. He also serves as epidemiologist and Infectious Disease Director of the Baptist Memorial Hospital Heart Lung Transplant Program, as well as co-Chair of the Infection Control Committee and Chairman of the System Antibiotic Stewardship Committee at Baptist Memorial Hospital. He is a member of the Mycoses Study Group Education and Research Consortium and a member of the Infectious Disease Society of America.
He has previously served as Chief of Staff, Department of Medicine Chairman, Formulary Committee Chairman, and as a member of the Metropolitan Board of Directors at Baptist Memorial Hospital in Memphis. Currently, Dr. Threlkeld serves as a member of the American Board of Internal Medicine Infectious Disease Board Exam Committee.
He received his undergraduate degree at Rhodes College and attended the University of Alabama medical school in Birmingham (UAB). He completed internal medicine residency and a Chief Medical Resident year at UAB. He then completed a fellowship in infectious disease at Massachusetts General Hospital and received the Massachusetts Infectious Disease Society Edward H. Kass Award for Clinical Excellence.
As of May 2019, Dr. Threlkeld reported the following external relationships:
Dr. Threlkeld serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- Baptist Memorial Health Care Corporation, Epidemiologist, Member of Baptist Cardiac Transplant Program, receiving compensation for transplant committee weekly meetings; Dr. Threlkeld is also chair of their Credentials Committee.
Darcy Wooten, MD
Dr. Darcy Wooten is Associate Professor of Medicine in the Division of Infectious Diseases and Global Public Health at University of California San Diego (UCSD). She also serves as the Associate Program Director for the ID Fellowship Training Program at UCSD.
Dr. Wooten attended Stanford University for her undergraduate studies in Human Biology. She taught Human Biology at Stanford for one year after graduating before she she entered a joint MD/MS program at UC San Francisco and UC Berkeley. She stayed on at UCSF for Internal Medicine residency and then completed her Infectious Diseases fellowship at UC Los Angeles, Harbor.
As of April 2021, Dr. Wooten reported no external relationships.